How much funding has Amplitude Therapeutics raised?

Amplitude Therapeutics has raised $1.0M in total funding, most recently a Grant round.

What industry is Amplitude Therapeutics in?

Amplitude Therapeutics operates in Biotech, Healthcare.

Amplitude Therapeutics

Q: Who are Amplitude Therapeutics's investors?

Amplitude Therapeutics's investors include Coalition for Epidemic Preparedness Innovations (CEPI).

Building the future of RNA Medicine.

Biotech

Healthcare

Business Model: B2B
Website: amplitude-tx.com
Total Funding: $1.0M

Last Round: $1.0M GrantMar 2024
Rounds: 1

About

Amplitude Therapeutics is a biotechnology company focused on developing trans-amplifying mRNA (ta-mRNA) and self-amplifying RNA technologies for next-generation vaccine applications. The company's platform leverages RNA amplification to enable lower-dose, more potent vaccines, with preclinical programs targeting infectious disease indications. Amplitude Therapeutics aims to build the future of RNA medicine by combining innovative RNA delivery and amplification approaches to address unmet medical needs in vaccinology.

Summary

Amplitude Therapeutics is a Biotech company. It has raised $1.0M in total across 1 round, most recently a $1.0M Grant round in Mar 2024. Investors include Coalition for Epidemic Preparedness Innovations (CEPI).